DISCLAIMER: FOR RESEARCH USE ONLY. The material provided is "as is", and using TOPOGRAPH is without warranties of any kind, either expressed or implied. The content provided by this resource CANNOT substitute for clinical judgement or professional oncology advice. Improper use of this resource may lead to harm.

NOTE: The haematology contents of this resource is currently under review and in the process of being updated.

Therapy-Oriented Precision Oncology Guidelines for Recommending Anti-cancer PHarmaceuticals

Database version: 20260517 (AU)

273
Gene and protein biomarkers

79
Combination biomarkers

13
Complex biomarkers

1201
Simple mutations

482
Variant groups

185
Protein expressions

185
Amplification deletions

358
Fusions and Rearrangements

5
Splice variants

7
Methylations

27
Germline mutations

46
Common cancers

82
T1

86
T2

168
T3

295
T4

10
R1

180
R2

25
Less common cancers

19
T1

12
T2

45
T3

110
T4

0
R1

22
R2

185
Rare cancers

39
T1

46
T2

127
T3

381
T4

6
R1

154
R2

© 2020-2026, Garvan Institute of Medical Research, University of Sydney, and Omico
The Kinghorn Cancer Centre, 370 Victoria Street, Darlinghurst NSW 2010, Australia.